The initial characterization of rearrangements involving the anaplastic lymphoma kinase (ALK+)-activating gene occurred in individuals diagnosed with anaplastic large cell lymphoma (ALCL). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.